Halozyme Therapeutics Inc (HALO)

[Fred Kadiddlehopper]

Well, that is the million dollar question. LOL! I can only point to R. Kirk's history. He is a billionaire with a capital B. He made the leap into that category when he sold New River Pharma and extracted every bit of value from that sale.
Nobody on any message board knows what will happen with HALO but it is known that Mr. Kirk knows how to make a deal. If he remains confident in the Halozyme pipeline after all that has transpired, he will sit pat and wait for the right offer. The value of HALO comes from three sources which I place in order of importance to the company:

1. rhuPH20 + other existing drugs for a conversion to SC use and concommitant patent extensions
2. the ultrafast insulin program
3. Hylenex
4. the cancer program
5. the HTI501 program

Cancer could shoot straight to the top but it is too soon to say.

In my opinion, the definition of "the right deal" is many times where we are at now. Frankly, if it were sold for anything less than $50 I'd be disappointed. However, that price presupposes Kirk's continued confidence in HALO's assets. If he starts getting the willies about the #'s 1 & 2 above, then the selling price gets a lot cheaper because they are the only path to near term profitability. HALO, must soon become self-sustaining via cash flow from #'s 1-3. Once it is clear to the markets that the company will be a profit making concern then the inherent value will certainly be unlocked. As a public company we investors know a lot; however, you can bet that Mr. Kirk knows a lot more. So, we wait...
Good luck!
-Fritz